UniProtKB/SwissProt variant VAR

Variant information

Variant position:

211

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

Disease [Disclaimer]

The variants are classified into three categories: Disease, Polymorphism and Unclassified.

Disease: Variants implicated in disease according to literature reports.
Polymorphism: Variants not reported to be implicated in disease.
Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:

From Lysine (K) to Glutamate (E) at position 211 (K211E, p.Lys211Glu).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from large size and basic (K) to medium size and acidic (E)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Involvement in disease:

Craniosynostosis 5 (CRS5) [MIM:615529]: A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability. {ECO:0000269|PubMed:22829454}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.

The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:

In CRS5; low-penetrance mutation associated with disease susceptibility; results in gain-of-function.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs281865154 [ dbSNP | Ensembl ]

Sequence information

Variant position:

211

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

411

The length of the canonical sequence.

Location on the sequence:

QDRASSDLPSPLEKADSESN K GKKRRNRTTFTSYQLEELEK

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         QDRASSDLPSPLEKADSESNKGKKRRNRTTFTSYQLEELEK

Mouse                         QDRASAEIPSPLEKTDSESNKGKKRRNRTTFTSYQLEELEK

Bovine                        QDRASADLPSPMEKADSESNKGKKRRNRTTFTSYQLEELEK

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 411	Homeobox protein aristaless-like 4
Modified residue	200 – 200	Phosphoserine

Literature citations

ALX4 gain-of-function mutations in nonsyndromic craniosynostosis.
Yagnik G.; Ghuman A.; Kim S.; Stevens C.G.; Kimonis V.; Stoler J.; Sanchez-Lara P.A.; Bernstein J.A.; Naydenov C.; Drissi H.; Cunningham M.L.; Kim J.; Boyadjiev S.A.;
Hum. Mutat. 33:1626-1629(2012)
Cited for: VARIANTS CRS5 PHE-7 AND GLU-211; VARIANT LEU-306; CHARACTERIZATION OF VARIANTS CRS5 PHE-7 AND GLU-211; CHARACTERIZATION OF VARIANT LEU-306;

UniProtKB/Swiss-Prot Q9H161: Variant p.Lys211Glu